Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Amarin Corp Plc
(NQ:
AMRN
)
6.980
USD
-0.070 (-0.99%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Amarin Corp Plc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
VFC's Stock House Weekly Stock Watch, Week of 17 December
December 18, 2012
from
EmailWire.Com Press Releases
Perfect Trade Setups, How to Play MDBX, STSI, ZGNX and AMRN
December 17, 2012
from
Marketwired News Releases
Amarin Announces Completion of Dosing in a Fixed-Dose Combination Study With Vascepa(R) and a Leading Statin
December 17, 2012
from
GlobeNewswire News Releases
Perfect Trade Setups, How to Play AAPL, MCP, AMRN and SD
December 14, 2012
from
Marketwired News Releases
Amarin Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa(R) and FDA Approved MARINE Indication
December 13, 2012
Strengthens Positioning of Vascepa for Exclusivity Into 2030
Read More
from
GlobeNewswire News Releases
Strategy Behind Our Success, We Get in Early: AMRN, VRX, TEVA and PFE
December 12, 2012
from
Marketwired News Releases
David Stack Appointed to Amarin Board of Directors
December 12, 2012
from
GlobeNewswire News Releases
The Real Story Behind DNDN, AMRN, ASML and CYCC
December 11, 2012
from
Marketwired News Releases
Amarin Announces Additional Vascepa(R) (icosapent ethyl) Supplier
December 11, 2012
Fourth API Supplier Further Solidifies Worldwide Supply Chain
Read More
from
GlobeNewswire News Releases
Critical Earnings Forecast Alerts: SandRidge Energy, Amarin, Broadcom, EMC, Verizon, and Genworth
December 10, 2012
from
PR Newswire
Free Research Reports on ABMD, AMRN, GTIM and SWHC Issued by the Bedford Report
December 10, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
VFC's Stock House Weekly Stock Watch, Week of 10 December
December 10, 2012
from
EmailWire.Com Press Releases
Amarin Announces $100 Million Non-Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives
December 06, 2012
from
GlobeNewswire News Releases
Amarin Announces U.S. Patent 8,324,195 Issuance for Vascepa(R)
December 04, 2012
Issuance for 13/349,150 Application
Read More
from
GlobeNewswire News Releases
Biotech Industry Experiencing More FDA New Drug Approvals in 2012
November 28, 2012
Five Star Equities Provides Stock Research on Amarin and InterMune
Read More
from
Marketwired News Releases
Free Research Reports on ACAD, AMRN, CAG and THO Issued by the Bedford Report
November 28, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
Amarin Announces U.S. Patent 8,318,715 Issuance for Vascepa(R)
November 27, 2012
Issuance for 13/282,145 Application
Read More
from
GlobeNewswire News Releases
Amarin Announces Notification of Patent Allowance for U.S. Application 13/610,247 Related to Vascepa(R) and FDA Approved MARINE Indication
November 26, 2012
Strengthens Positioning of Vascepa for Exclusivity Into 2030
Read More
from
GlobeNewswire News Releases
Free Research Reports on AMRN, ARNA, GNOM and SQNM Issued by the Bedford Report
November 22, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
VFC's Stock House Stock Watch Wednesday, 21 November
November 21, 2012
from
EmailWire.Com Press Releases
Amarin Announces U.S. Patent 8,314,086 Issuance for Vascepa(R)
November 20, 2012
Issuance for 13/284,408 Application
Read More
from
GlobeNewswire News Releases
Amarin Announces Notification of Patent Allowance for U.S. Application 13/608,775 Related to Vascepa(R) and FDA Approved MARINE Indication
November 19, 2012
Strengthens Positioning of Vascepa for Exclusivity Into 2030
Read More
from
GlobeNewswire News Releases
VFC's Stock House Weekly Stock Watch, Week of 19 November
November 19, 2012
from
EmailWire.Com Press Releases
VFC's Stock House Weekly Stock Watch, Week of 12 November
November 12, 2012
from
EmailWire.Com Press Releases
Amarin Reports Third Quarter 2012 Financial Results and Provides Update on Operations
November 08, 2012
Conference Call Set for 4:30 p.m. EST Today
Read More
from
GlobeNewswire News Releases
Amarin to Report Third Quarter 2012 Financial Results and Host Conference Call on November 8, 2012
November 01, 2012
Conference Call Set for 4:30 p.m. ET on November 8th
Read More
from
GlobeNewswire News Releases
Amarin Announces U.S. Patent 8,298,554 Issuance for Vascepa(TM)
October 30, 2012
Issuance for '885 Application
Read More
from
GlobeNewswire News Releases
Amarin Announces Issuance of U.S. Patents 8,793,727 and 8,293,728 for Vascepa(TM)
October 23, 2012
Issuances for '889 and '153 Applications
Read More
from
GlobeNewswire News Releases
Critical Alerts For Travelers, MGM Mirage, Textron, Amarin, and Sourcefire Released By InvestorsObserver
October 19, 2012
from
PR Newswire
Hot Stocks: Freeport-McMoRan, EnCana, MannKind, Amarin, Philip Morris, and Marathon Oil
October 19, 2012
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here